When.com Web Search

  1. Ads

    related to: duke cancer center clinical trials

Search results

  1. Results From The WOW.Com Content Network
  2. Duke Cancer Institute - Wikipedia

    en.wikipedia.org/wiki/Duke_Cancer_Institute

    The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. [1] Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States.

  3. Anil Potti - Wikipedia

    en.wikipedia.org/wiki/Anil_Potti

    Anil Potti is a physician and former Duke University associate professor and cancer researcher, focusing on oncogenomics. He, along with Joseph Nevins, are at the center of a research fabrication scandal at Duke University. [1] [2] [3] On 9 November 2015, the Office of Research Integrity (ORI) found that Potti had engaged in research misconduct ...

  4. After 30 years of research, pill developed at Duke for ... - AOL

    www.aol.com/news/30-years-research-pill...

    After six years of painful injections, Stephanie Walker has had enough. Every 28 days, she drives an hour to Duke’s Cancer center to get 50 mL slowly injected into her glute muscles.

  5. Duke University School of Medicine - Wikipedia

    en.wikipedia.org/wiki/Duke_University_School_of...

    The Duke Clinical Research Institute (DCRI) performs all aspects of clinical research ranging from: Phase I through Phase IV clinical trials; outcomes research; registries of more than 100,000 patients; clinical research networks such as the Pediatric Trials Network; and economic and quality of life studies in populations spanning more than 20 ...

  6. Gary Herbert Lyman - Wikipedia

    en.wikipedia.org/wiki/Gary_Herbert_Lyman

    Gary Herbert Lyman is an American academic hematologist, medical oncologist, and cancer researcher. [1]Lyman is most known for his efforts in managing the adverse effects of cancer treatment including neutropenia and thrombosis among other toxicities along with establishing the clinical application of colony-stimulating factors and oral anticoagulants.

  7. Matthias Gromeier - Wikipedia

    en.wikipedia.org/wiki/Matthias_Gromeier

    While at Stony Brook, in 1993, Gromeier engineered the virus he’d later use in the Duke cancer trials, swapping out a critical part of the structure with the equivalent part of the human rhinovirus, which causes the common cold. Gromeier also studied receptors, proteins on the surface of cells that viruses evolve to recognize.

  1. Ads

    related to: duke cancer center clinical trials